Sayed Aliul Hasan Abdi
Role not yet determined Is this you? Add your title
Also affiliated: JSS Academy of Higher Education and Research (2012); Qassim University (2017); University of Tennessee Health Science Center (2023); Jamia Hamdard (2014–2020); University of Arkansas Medical Center (2025–2026); JSS College of Pharmacy (2012); Al Baha University (2020–2026)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Sayed Aliul Hasan Abdi's research focuses on investigating the molecular mechanisms underlying various diseases and the potential therapeutic effects of compounds. His work utilizes computational approaches, including molecular docking and dynamics simulations, to screen and analyze the interactions between small molecules and biological targets. This approach has been applied to study the role of oxidative stress in acute kidney injury, the efficacy of resveratrol as a potential treatment, and the disruptive effects of environmental chemicals like hexaconazole on hormone biosynthesis and acetylcholinesterase activity.
Abdi has also explored the development of in silico vaccine candidates, as demonstrated by his work on a multi-epitope-based vaccine for monkeypox. His research further extends to identifying new therapeutic agents, such as morusflavone for prostate cancer by targeting CYP17A1. He has also examined adverse drug reactions, including trends in severe cutaneous adverse reactions to anti-seizure medications in Asian populations. His scholarly contributions include 43 publications with 451 citations and an h-index of 11.
Metrics
- h-index: 11
- Publications: 38
- Citations: 479
Positions
-
Senior Research Fellow 2013–2017Jamia Hamdard Pharmacology & Toxicology ORCID
Selected Publications
-
RETRACTED: Abdi et al. Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief. Int. J. Mol. Sci. 2025, 26, 10432 (2026)
-
RETRACTED: Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief (2025)
-
Mitochondrial Dynamics in Aging Heart (2025)
-
Alternative Splicing of Serum Response Factor Reveals Isoform-Specific Remodeling in Cardiac Diseases (2025)
-
The Long-Term Cardiovascular Risks of Duloxetine Use in Older Adults: A Retrospective Medical Record-Based Adverse Drug Reaction Assessment (2024)
Collaboration Network
Top Collaborators
- The Long-Term Cardiovascular Risks of Duloxetine Use in Older Adults: A Retrospective Medical Record-Based Adverse Drug Reaction Assessment
- Mitochondrial Dynamics in Aging Heart
- RETRACTED: Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief
- Alternative Splicing of Serum Response Factor Reveals Isoform-Specific Remodeling in Cardiac Diseases
- RETRACTED: Abdi et al. Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief. Int. J. Mol. Sci. 2025, 26, 10432
- The Long-Term Cardiovascular Risks of Duloxetine Use in Older Adults: A Retrospective Medical Record-Based Adverse Drug Reaction Assessment
- Mitochondrial Dynamics in Aging Heart
- RETRACTED: Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief
- Alternative Splicing of Serum Response Factor Reveals Isoform-Specific Remodeling in Cardiac Diseases
- RETRACTED: Abdi et al. Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief. Int. J. Mol. Sci. 2025, 26, 10432
- Mitochondrial Dynamics in Aging Heart
- Alternative Splicing of Serum Response Factor Reveals Isoform-Specific Remodeling in Cardiac Diseases
- Mitochondrial Dynamics in Aging Heart
- RETRACTED: Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief
- The Long-Term Cardiovascular Risks of Duloxetine Use in Older Adults: A Retrospective Medical Record-Based Adverse Drug Reaction Assessment
- Alternative Splicing of Serum Response Factor Reveals Isoform-Specific Remodeling in Cardiac Diseases
- Alternative Splicing of Serum Response Factor Reveals Isoform-Specific Remodeling in Cardiac Diseases
- Mitochondrial Dynamics in Aging Heart
- Mitochondrial Dynamics in Aging Heart
- Mitochondrial Dynamics in Aging Heart
- RETRACTED: Abdi et al. Duloxetine, an SNRI, Targets pSTAT3 Signaling: In-Silico, RNA-Seq and In-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief. Int. J. Mol. Sci. 2025, 26, 10432
Similar Researchers
Based on overlapping research topics